Spots Global Cancer Trial Database for Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
Official Title: Randomized Phase II Study of 3 vs 6 Courses of Neoadjuvant Carboplatin-paclitaxel Chemotherapy in Stage IIIC or IV Epithelial Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma
Study ID: NCT02125513
Interventions
Study Description
Brief Summary: The purpose of this study is to define whether 6 courses of neoadjuvant chemotherapy can lead to a higher rate of complete cytoreductive surgery compared with 3 courses of neoadjuvant chemotherapy in patients with epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
S.Orsola-Malpighi Hospital, Bologna, , Italy
Azienda Ospedaliero-Universitaria di Parma - Oncologia Medica, Parma, , Italy
IRCCS Ospedale Santa Maria Nuova, Reggio Emilia, , Italy
Fondazione Policlinico Universitario A. Gemelli, Rome, , Italy
Azienda Ospedaliero-Universitaria Santa Maria della Misericordia di Udine, Reparto di Oncologia, Udine, , Italy
Contact Details
Name: Claudio Zamagni, MD
Affiliation: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
